Journal of the American Chemical Society
Page 6 of 8
Author Contributions
Chemical Society (Resumed) 1965, 4831-4837. (b) Sundberg, R. J.
Deoxygenation of Nitro Groups by Trivalent Phosphorus. Indoles
from o-Nitrostyrenes. J. Org. Chem. 1965, 30, 3604-3610.
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
§
J.S.Z. and C.J.L. contributed equally.
(
7) Genung, N. E.; Wei, L.; Aspnes, G. E. Regioselective
ORCID
Synthesis of 2H-Indazoles Using a Mild, One-Pot Condensation–
Cadogan Reductive Cyclization. Org. Lett. 2014, 16, 3114-3117.
(8) Nykaza, T. V.; Harrison, T. S.; Ghosh, A.; Putnik, R. A.;
Radosevich, A. T. A Biphilic Phosphetane Catalyzes N–N Bond-
Forming Cadogan Heterocyclization via PIII/PV═O Redox
Cycling. J. Am. Chem. Soc. 2017, 139, 6839-6842.
Jie S. Zhu: 0000-0003-3009-4135
Makhluf J. Haddadin: 0000-0001-9986-149X
Dean J. Tantillo: 0000-0002-2992-8844
Mark J. Kurth: 0000-0001-8496-6125
(
9) Schoene, J.; Bel Abed, H.; Schmieder, P.; Christmann, M.;
ACKNOWLEDGMENT
Nazaré, M. A General One-Pot Synthesis of 2H-Indazoles Using
an Organophosphorus–Silane System. Chem. Eur. J. 2018, 24,
9
(10) Chung, C. K.; Bulger, P. G.; Kosjek, B.; Belyk, K. M.; Rivera,
N.; Scott, M. E.; Humphrey, G. R.; Limanto, J.; Bachert, D. C.;
Emerson, K. M. Process Development of C–N Cross-Coupling
and Enantioselective Biocatalytic Reactions for the Asymmetric
Synthesis of Niraparib. Org. Process Res. Dev. 2014, 18, 215-227.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
The authors gratefully acknowledge financial support from
the National Institutes of Health (DK072517 and DK067003)
and NSF XSEDE program (CHE030089 to D.J.T.). Funding for
NMR spectrometers were provided by National Science
Foundation (DBI722538 and CHE9808183) and NIH National
Institute of Environmental Health Sciences ES00570713. J.S.Z.
is supported by the UC Davis Tara K. Telford CF Fund, UC
Davis Dissertation Year Fellowship, and R. Bryan Miller
Graduate Fellowship. N.K. is supported by the UC Davis
Provost’s Undergraduate Fellowship. We dedicate this work
in memory of Tara K. Telford, a young wife and mother of
twins, who inspired everyone who knew her by living so gra-
ciously and resolutely with cystic fibrosis.
090-9100.
(
11) Davies, I. W.; Guner, V. A.; Houk, K. N. Theoretical Evidence
for Oxygenated Intermediates in the Reductive Cyclization of
Nitrobenzenes. Org. Lett. 2004, 6, 743-746.
(
D.; González, M.; Porcal, W.; Denicola, A.; Piro, O. E.;
Castellano, E. E.; Sant’Anna, C. M. R.; Barreiro, E. J. New potent
5
12) (a) Aguirre, G.; Boiani, L.; Boiani, M.; Cerecetto, H.; Maio, R.
-substituted benzofuroxans as inhibitors of Trypanosoma cruzi
growth: Quantitative structure–activity relationship studies.
Biorg. Med. Chem. 2005, 13, 6336-6346. (b) Ruggeri, S. G.; Bill, D.
R.; Bourassa, D. E.; Castaldi, M. J.; Houck, T. L.; Ripin, D. H. B.;
Wei, L.; Weston, N. Safety vs Efficiency in the Development of a
High-Energy Compound. Org. Process Res. Dev. 2003, 7, 1043-
1047. (c) Sheng, J.; He, R.; Xue, J.; Wu, C.; Qiao, J.; Chen, C. Cu-
Catalyzed π-Core Evolution of Benzoxadiazoles with
Diaryliodonium Salts for Regioselective Synthesis of Phenazine
Scaffolds. Org. Lett. 2018, 20, 4458-4461. (d) Wang, L.; Zhang,
Y.-Y.; Wang, L.; Liu, F.-y.; Cao, L.-L.; Yang, J.; Qiao, C.; Ye, Y.
Benzofurazan derivatives as antifungal agents against
phytopathogenic fungi. Eur. J. Med. Chem. 2014, 80, 535-542.
(13) Zhu, J. S.; Kraemer, N.; Shatskikh, M. E.; Li, C. J.; Son, J.-H.;
Haddadin, M. J.; Tantillo, D. J.; Kurth, M. J. N–N Bond Formation
between Primary Amines and Nitrosos: Direct Synthesis of 2-
Substituted Indazolones with Mechanistic Insights. Org. Lett.
REFERENCES
(1) Haddadin, M, J.; Conrad, W. E.; Kurth, M. J.. The Davis-
Beirut Reaction:
Indazolones. Recent Biological Activity of Indazoles. Mini-Rev.
Med. Chem. 2012, 12, 1293-1300.
A Novel Entry into 2H-indazoles and
(
2) Jones, P.; Altamura, S.; Boueres, J.; Ferrigno, F.; Fonsi, M.;
Giomini, C.; Lamartina, S.; Monteagudo, E.; Ontoria, J. M.;
Orsale, M. V.; Palumbi, M. C.; Pesci, S.; Roscilli, G.; Scarpelli, R.;
Schultz-Fademrecht, C.; Toniatti, C.; Rowley, M. Discovery of 2-
{4-[(3S)-Piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide
(
MK-4827): A Novel Oral Poly(ADP-ribose)polymerase (PARP)
Inhibitor Efficacious in BRCA-1 and -2 Mutant Tumors. J. Med.
Chem. 2009, 52, 7170-7185.
(
3) Harris, P. A.; Boloor, A.; Cheung, M.; Kumar, R.; Crosby, R.
M.; Davis-Ward, R. G.; Epperly, A. H.; Hinkle, K. W.; Hunter, R.
N.; Johnson, J. H.; Knick, V. B.; Laudeman, C. P.; Luttrell, D. K.;
Mook, R. A.; Nolte, R. T.; Rudolph, S. K.; Szewczyk, J. R.;
Truesdale, A. T.; Veal, J. M.; Wang, L.; Stafford, J. A. Discovery of
2
(
018, 20, 4736-4739.
14) Jiao, L.; Liang, Y.; Xu, J. Origin of the Relative
Stereoselectivity of the β-Lactam Formation in the Staudinger
Reaction. J. Am. Chem. Soc. 2006, 128, 6060-6069.
(15) Amarnath, V.; Anthony, D. C.; Amarnath, K.; Valentine, W.
M.; Wetterau, L. A.; Graham, D. G. Intermediates in the Paal-
Knorr synthesis of pyrroles. J. Org. Chem. 1991, 56, 6924-6931.
5
-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-
pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib),
Novel and Potent Vascular Endothelial Growth Factor
Receptor Inhibitor. J. Med. Chem. 2008, 51, 4632-4640.
4) Pfefferkorn, J. A.; Tu, M.; Filipski, K. J.; Guzman-Perez, A.;
a
(
16) Wei, J.; Shaw, J. T. Diastereoselective Synthesis of γ-Lactams
by a One-Pot, Four-Component Reaction. Org. Lett. 2007, 9,
077-4080.
17) Chizhova, M.; Khoroshilova, O.; Dar’in, D.; Krasavin, M.
(
Bian, J.; Aspnes, G. E.; Sammons, M. F.; Song, W.; Li, J.-C.; Jones,
C. S.; Patel, L.; Rasmusson, T.; Zeng, D.; Karki, K.; Hamilton, M.;
Hank, R.; Atkinson, K.; Litchfield, J.; Aiello, R.; Baker, L.; Barucci,
N.; Bourassa, P.; Bourbounais, F.; D’Aquila, T.; Derksen, D. R.;
MacDougall, M.; Robertson, A. The design and synthesis of
indazole and pyrazolopyridine based glucokinase activators for
the treatment of Type 2 diabetes mellitus. Bioorg. Med. Chem.
Lett. 2012, 22, 7100-7105.
4
(
Unusually Reactive Cyclic Anhydride Expands the Scope of the
Castagnoli–Cushman Reaction. J. Org. Chem. 2018, 83, 12722-
1
(
2733.
18) Mfuh, A. M.; Larionov, O. V. Heterocyclic N-Oxides - An
Emerging Class of Therapeutic Agents. Current Medicinal
Chemistry 2015, 22, 2819-2857.
(
Bagdon, R. E. THE PSYCHOSEDATIVE PROPERTIES OF
METHAMINODIAZEPOXIDE. J. Pharmacol. Exp. Ther. 1960, 129,
(5) Aman, W.; Lee, J.; Kim, M.; Yang, S.; Jung, H.; Hah, J.-M.
Discovery of highly selective CRAF inhibitors, 3-carboxamido-
19) Randall, L. O.; Schallek, W.; Heise, G. A.; Keith, E. F.;
2
H-indazole-6-arylamide: In silico FBLD design, synthesis and
evaluation. Bioorg. Med. Chem. Lett. 2016, 26, 1188-1192.
6) (a) Cadogan, J. I. G.; Cameron-Wood, M.; Mackie, R. K.;
1
(
63-171.
20) Olsen, E. A.; Weiner, M. S.; Delong, E. R.; Pinnell, S. R.
(
Searle, R. J. G. 896. The reactivity of organophosphorus
compounds. Part XIX. Reduction of nitro-compounds by triethyl
phosphite:
Topical minoxidil in early male pattern baldness. J. Am. Acad.
Dermatol 1985, 13, 185-192.
(
a convenient new route to carbazoles, indoles,
21) von Pawel, J.; von Roemeling, R.; Gatzemeier, U.; Boyer, M.;
indazoles, triazoles, and related compounds. Journal of the
Elisson, L. O.; Clark, P.; Talbot, D.; Rey, A.; Butler, T. W.; Hirsh,
6
ACS Paragon Plus Environment